Experienced in Viral Hemorrhagic Fever

Pope Kosalaraksa

Khon Kaen, TH 
Experienced in Viral Hemorrhagic Fever
Khon Kaen, TH 
OverviewLocationsClinical Research

Overview

Pope Kosalaraksa practices in Khon Kaen, Thailand. Mr. Kosalaraksa is rated as an Experienced expert by MediFind in the treatment of Viral Hemorrhagic Fever. His top areas of expertise are HIV/AIDS, Japanese Encephalitis, Tetanus, and Dengue Fever.

His clinical research consists of co-authoring 110 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Viral Hemorrhagic Fever.

Gender
Male

Locations

Khon Kaen, Thailand
Other Locations
Bangkok, Thailand

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children
A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children
Enrollment Status: Completed
Publish Date: January 09, 2026
Intervention Type: Drug
Study Drug: E/C/F/TAF
Study Phase: Phase 2/Phase 3
A Phase 2/3, Multicenter, Open-label, Multicohort Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 Infected, Virologically Suppressed Pediatric Participants
A Phase 2/3, Multicenter, Open-label, Multicohort Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 Infected, Virologically Suppressed Pediatric Participants
Enrollment Status: Active_not_recruiting
Publish Date: June 26, 2025
Intervention Type: Drug
Study Drugs: Atazanavir, Darunavir, Cobicistat, Background regimen
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

108 Total Publications

Epidemiology, outcomes, and factors associated with mortality in pediatric tuberculosis in Thailand: A National Health Security Office Data Analysis from 2015 to 2023.
Epidemiology, outcomes, and factors associated with mortality in pediatric tuberculosis in Thailand: A National Health Security Office Data Analysis from 2015 to 2023.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: August 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kosalaraksa's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile